Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Hypoxia-Induced Sarcoplasmic Reticulum Ca2+ Leak Is Reversed by Ryanodine Receptor Stabilizer JTV-519 in HL-1 Cardiomyocytes

MD. Trinh, I. Fiserova, L. Vacek, M. Marek, J. Pala, P. Tousek, J. Polak

. 2022 ; 26 (6) : 476-484. [pub] -

Jazyk angličtina Země Turecko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22018092

BACKGROUND: To assess whether hypoxia, as can be found in obstructive sleep apnea syndrome, is causally associated with the development of heart failure through a direct effect on calcium leakage from the sarcoplasmic reticulum. METHODS: The impact of hypoxia on sarcoplasmic reticulum calcium leakage and expres- sion of RyR2 (ryanodine receptor2) and SERC2a (sarcoplasmic reticulum Ca2+ATPase 2a) was investigated together with the outcomes of JTV-519 and S107 treatment. HL-1 car- diomyocytes were cultured for 7 days on gas-permeable cultureware under control (12% O2) or hypoxic (1% O2) conditions with or without JTV-519 or S107. SRCL was assessed using a Fluo-5N probe. Gene and protein expression was analyzed using qPCR and western blotting. RESULTS: Hypoxic exposure increased sarcoplasmic reticulum calcium leakage by 39% and reduced RyR2 gene expression by 52%. No effect on RyR2 protein expression was observed. Treatment with 1μM JTV-519 reduced sarcoplasmic reticulum calcium leakage by 52% and 35% under control and hypoxic conditions, respectively. Administration of 1 μM JTV-519 increased RyR2 gene expression by 89% in control conditions. No effect on SRCL, RyR2, or SERC2a gene, or protein expression was observed with S107 treatment. CONCLUSION: Hypoxia increased sarcoplasmic reticulum calcium leakage which was ame- liorated by JTV-519 treatment independently of gene or protein expression. JTV-519 rep- resents a possible treatment for obstructive sleep apnea-associated HF.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018092
003      
CZ-PrNML
005      
20250325084011.0
007      
ta
008      
220720s2022 tu f 000 0|eng||
009      
AR
024    7_
$a 10.5152/AnatolJCardiol.2022.1223 $2 doi
035    __
$a (PubMed)35703484
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a tu
100    1_
$a Trinh, D. M. $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Cardiology, University Hospital Královské Vinohrady, Prague, Czech Republic $7 xx0330289
245    10
$a Hypoxia-Induced Sarcoplasmic Reticulum Ca2+ Leak Is Reversed by Ryanodine Receptor Stabilizer JTV-519 in HL-1 Cardiomyocytes / $c MD. Trinh, I. Fiserova, L. Vacek, M. Marek, J. Pala, P. Tousek, J. Polak
520    9_
$a BACKGROUND: To assess whether hypoxia, as can be found in obstructive sleep apnea syndrome, is causally associated with the development of heart failure through a direct effect on calcium leakage from the sarcoplasmic reticulum. METHODS: The impact of hypoxia on sarcoplasmic reticulum calcium leakage and expres- sion of RyR2 (ryanodine receptor2) and SERC2a (sarcoplasmic reticulum Ca2+ATPase 2a) was investigated together with the outcomes of JTV-519 and S107 treatment. HL-1 car- diomyocytes were cultured for 7 days on gas-permeable cultureware under control (12% O2) or hypoxic (1% O2) conditions with or without JTV-519 or S107. SRCL was assessed using a Fluo-5N probe. Gene and protein expression was analyzed using qPCR and western blotting. RESULTS: Hypoxic exposure increased sarcoplasmic reticulum calcium leakage by 39% and reduced RyR2 gene expression by 52%. No effect on RyR2 protein expression was observed. Treatment with 1μM JTV-519 reduced sarcoplasmic reticulum calcium leakage by 52% and 35% under control and hypoxic conditions, respectively. Administration of 1 μM JTV-519 increased RyR2 gene expression by 89% in control conditions. No effect on SRCL, RyR2, or SERC2a gene, or protein expression was observed with S107 treatment. CONCLUSION: Hypoxia increased sarcoplasmic reticulum calcium leakage which was ame- liorated by JTV-519 treatment independently of gene or protein expression. JTV-519 rep- resents a possible treatment for obstructive sleep apnea-associated HF.
650    _2
$a vápník $x metabolismus $7 D002118
650    _2
$a lidé $7 D006801
650    _2
$a hypoxie $7 D000860
650    _2
$a kardiomyocyty $7 D032383
650    12
$a ryanodinový receptor vápníkového kanálu $x genetika $x metabolismus $x farmakologie $7 D019837
650    12
$a sarkoplazmatické retikulum $x metabolismus $7 D012519
650    _2
$a thiazepiny $7 D013841
655    _2
$a časopisecké články $7 D016428
700    1_
$a Fiserova, Ivana $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Vacek, Lukas $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Marek, Marek $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Pala, Jan $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Tousek, Petr $u Department of Cardiology, University Hospital Královské Vinohrady, Prague, Czech Republic
700    1_
$a Polak, Jan $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Internal Medicine, University Hospital Královské Vinohrady, Prague, Czech Republic
773    0_
$w MED00207061 $t Anatolian journal of cardiology $x 2149-2271 $g Roč. 26, č. 6 (2022), s. 476-484
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35703484 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20250325084012 $b ABA008
999    __
$a ok $b bmc $g 1821925 $s 1169335
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 26 $c 6 $d 476-484 $e - $i 2149-2271 $m Anatolian journal of cardiology $n Anatol J Cardiol $x MED00207061
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Možnosti archivace